Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay

Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay

Item

http://www.wikidata.org/entity/Q28251086

Q28251086

about

Cellular localizations and processing of the two molecular forms of the Hodgkin-associated Ki-1 (CD30) antigen. The protein kinase Ki-1/57 occurs in the nucleus Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells Cell membrane-specific epitopes on CD30: Potentially superior targets for immunotherapy.The role of CD30 in atopic disease.Anaplastic large cell lymphoma: pathological, molecular and clinical features.Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material.CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule Soluble CD30 levels as a diagnostic marker for bronchiolitis obliterans syndrome following human lung transplantation Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.Maternal serum soluble CD30 is increased in pregnancies complicated with acute pyelonephritis CD30-mediated signaling promotes the development of human T helper type 2-like T cells.BK Virus Load Associated with Serum Levels of sCD30 in Renal Transplant Recipients Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma.CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro.CD30: an important new target in hematologic malignancies.CD30+ neoplasms of the skin.Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis.Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation.Is Hodgkin's disease a unique entity?Biopathologic features of Hodgkin's disease.Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.Inhibition of metalloproteinases enhances the internalization of anti-CD30 antibody Ki-3 and the cytotoxic activity of Ki-3 immunotoxin.Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30.Reed-Sternberg cells and the TNF family of receptors/ligands.CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.B7-1 (CD80) as target for immunotoxin therapy for Hodgkin's disease.Pathobiology of anaplastic large cell lymphoma.Regulation of CD30 antigen expression and its potential significance for human disease.Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms.Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions.Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis.

P2860

Q24676791-83E3B285-658B-440F-904E-14A2EE3B61BF Q28208696-23B60CEA-0E32-4A44-9D50-BB49743102AA Q28281794-FDCB0A97-2FC9-4EE8-B32C-F1D44DF7D91D Q28362305-BFD562A1-024D-48EF-B0AC-F140188EA3D9 Q33841251-D7F1F851-683B-41EC-BE6A-16B732FEB20A Q34291177-DF77C5E5-2645-4D52-9CE5-4F3B35DAD51D Q34374218-A34B558E-9AEC-4CED-8539-2AC7C8556D79 Q35239255-4B061E4F-A3A7-4739-9250-7B735DB724EB Q35796182-760655D5-5A4D-4885-82AD-7958520E7CD8 Q36319913-514DBF0E-B9F3-4B56-B255-51383FD833E9 Q36512063-5C60B8E2-CF59-4551-96FB-ECA4B04D1D65 Q36534677-5349A4DC-84F8-4EBB-A9EC-912B88C274DA Q36569720-B726DF93-9AA2-420F-8C4D-DC10EF3244FC Q36672795-7F4419C2-70D3-45A0-9F6A-849FF7F41B27 Q36718807-801FE9E7-FE2E-494C-8365-7DA68B356838 Q37228493-FDDF48E9-0A2E-4547-922E-8B4034EC7328 Q37327528-C6103C41-339B-43E0-9F46-2D6E64FDB909 Q37880873-C15CB187-28DF-434E-AA76-B13EFAB9CFBF Q37919372-F869A1F6-BEA5-4DFE-AE4A-7CD99A8D5153 Q38375380-CA770B3D-B0C3-4F1D-BF95-899E671A57E6 Q39615506-8EAADEC8-CD4C-4A63-A506-D89DE3975C41 Q40358580-8235F54F-04ED-4A27-B04C-0612F56FA591 Q40536807-2EA39901-0E03-46AD-8286-3AF6C4EC2790 Q40548687-5B52EF5D-2674-42F9-9E74-FB8518A9677B Q40736248-2AA6B182-D15D-4E76-99B0-543748D1CC32 Q40749254-60A682A7-1322-4407-8B5A-866AD953AA7E Q40761212-7FBAA939-141C-472F-9FC7-6FA5824F0F0D Q40875592-8D213C5C-0DDC-48A0-AC28-2E379631EC2E Q41132552-FAF8095B-2F6B-4277-B0FF-06132EB02BE1 Q41137287-5FB00E08-8A30-4561-BAC6-4349F36B1129 Q41852473-958DD12D-812B-439C-902A-46478F0DA8FA Q42775424-1E1B5EDB-4FC9-4EEA-BEA4-B0D8F6F30058 Q44841471-D4C584B0-FCB8-4CC9-9E32-4347AA36EA38 Q47102763-CD3223EA-CFBE-49C6-8068-DDB2CE2ADABE Q49837454-1668FA61-E44B-4053-850C-AFDAF6133431 Q52022979-296DC025-0076-4C49-AA0D-1096FBF833D1

P2860

Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay

Item

http://www.wikidata.org/entity/Q28251086

description

1989 nî lūn-bûn

@nan

1989 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu